Overall, the results mentioned above indicated that SPP1, as a prognostic gene or biomarker, was not only significantly negatively correlated with the survival of patients with hepatocellular carcinoma (HCC), but it may also play a pivotal role in promoting the immunosuppressive tumor microenvironment and accelerating the progression of HCC. Here, SPP1 is linked to neoplasm.